MAPT and Alzheimer disease: AD is characterized by the presence of senile plaques (comprised of amyloid-β peptide (Aβ)) [3–5] and neurofibrillary tangles (NFTs) (formed by the aggregation of hyperphosphorylated tau) [6–8] in the brain, which cause synaptic dysfunction, neuron loss and marked glial activation [9].